Company: Solarvest Bioenergy Inc.
Listing : TSX Venture, Frankfurt
Ticker: SVS.V , 0ZJ:FRA
Market cap at time of publication: $18 MCAD
Stock price at time of publication: $0.41 CAD
Business: Patented plant based pharmaceuticals from algaes and Clean Energy Hydrogen production
Comparable peers: Else Nutrition market cap : 306 MCAD
Website: and for the omega 3 products:

The latest addition to the ESGFIREAT40 portfolio namely Solarvest Bioenergy introduced yesterday to the blog timely enough announced a very big and impressive potential business relationship today 6/4 2021 with 4,6 billion revenue company Scoular . The objective of the potential cooperation is to develop a sustianable supply of Omega-3 fatty acids. The goal of the development program is to develop protocols and process data for the efficient production of commercial volumes of Omega-3 fatty acids .

The development program satisfies both companies goal of sustainable supply of health enhancing food and will utilize the SVS algae plattform expertise combined with Scoular’s extensive knowledge, experience and activity in the global agricultural supply chain. Scoular is a supporter of responsible marine product sourcing and provide the marketplace with alternative food and feedstuffs that have a positive environmental and social impact.


ESG comment: My interpretation of this very exciting potential business relationship is that Scoular will likely test and analyze the algae platform by Solarvest in regards to the Omega-3 product line and if they are pleased with the results this should open up a massive opportunity for Solarvest both in terms of large scale production and also sales within the big network that Scoular has with actors in the agricultural business! Scoular is a 128 year old company with 4,6 BUSD in sales and has over 100 offices and facilities in North America and Asia. The company employs over 1000 individuals and the business is to buy, sell, store, handle and process grains and ingredients as well as manage transportation and logistics for customers worlwide.


 I own shares in this company personally and this is not to be considered financial advice, always do your own research!

Don’t forget to subscribe to this blog by pressing “follow” or going to the main page furthest down and sign up to receive news update as soon as they’re published!